Clinical Progress of Glutaminase Inhibitors Glutaminase inhibitors selectively target the overactive GLS in cancer cells, sparing GLS2 in normal cells: Blocking EMT (Epithelial-to-Mesenchymal Transition) : These inhibitors can help prevent EMT, which supports cancer spread
Immediately discontinue estrogen-alone therapy if a VTE occurs or is suspected
Others have struck partnerships leveraging complementary strengths: Zydus with Lupin and Torrent, Natco with Eris, Biocon with Ajanta
It can improve the firmness of the skin as well as its texture, successfully restoring a youthful appearance
The Glucagon Paradox The glucagon paradox refers to the unexpected possibility that a hormone traditionally associated with raising blood glucose may enhance weight loss when incorporated into balanced multi-receptor agonists
This designation supports academic research, pharmaceutical development and biotechnology research while complying with regulations